Back

Overexpression of Alpha-1 Antitrypsin Increases the Proliferation of Mesenchymal Stem Cells by Upregulation of Cyclin D1 and is Independent of the Wnt Signaling Pathway

Wolfe, B.; Muralidharan, P.; Lee, M. Y.; Wei, H.; Green, E.; Wang, H.; Strange, C.

2023-10-28 cell biology
10.1101/2023.10.28.564526 bioRxiv
Show abstract

Alaph-1 antitrypsin overexpressing mesenchymal stromal/stem cells (AAT-MSCs) showed improved innate properties with a faster proliferation rate when studied for their protective effects in mouse models of diseases. Here, we investigated the potential mechanism(s) by which AAT gene insertion increases MSC proliferation. Human bone marrow-derived primary or immortalized MSCs (iMSCs) or AAT-MSCs (iAAT-MSCs) were used in the study. Cell proliferation was measured by cell counting and cell cycle analysis. Possible pathways involved in the pro-proliferation effect of AAT were investigated by measuring mRNA and protein expression of key cell cycle genes. Interval cell counting showed increased proliferation in AAT-MSCs or iAAT-MSCs compared to their corresponding MSC controls. Cell cycle analysis revealed more cells progressing into the S and G2/M phases in iAAT-MSCs, with a notable increase in the cell cycle protein, Cyclin D1. Moreover, treatment with Cyclin D1 inhibitors showed that the increase in proliferation is due to Cyclin D1 and that the AAT protein is upstream and a positive regulator of Cyclin D1. Furthermore, AATs effect on Cyclin D1 is independent of the Wnt signaling pathway as there were no differences in the expression of regulatory proteins, including GSK3{beta} and {beta}-Catenin in iMSC and iAAT-MSCs. In summary, our results indicate that AAT gene insertion in an immortalized MSC cell line increases cell proliferation and growth by increasing Cyclin D1 expression and consequently causing cells to progress through the cell cycle at a significantly faster rate.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 12%
14.8%
2
Experimental Cell Research
24 papers in training set
Top 0.1%
7.0%
3
Stem Cells
28 papers in training set
Top 0.1%
7.0%
4
Stem Cell Research & Therapy
30 papers in training set
Top 0.1%
5.0%
5
Aging
69 papers in training set
Top 0.5%
4.5%
6
Scientific Reports
3102 papers in training set
Top 26%
4.4%
7
International Journal of Molecular Sciences
453 papers in training set
Top 2%
3.7%
8
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 1%
3.7%
50% of probability mass above
9
Pharmaceuticals
33 papers in training set
Top 0.3%
2.8%
10
Cells
232 papers in training set
Top 1%
2.1%
11
Biochemical and Biophysical Research Communications
78 papers in training set
Top 0.4%
1.9%
12
Biomedicines
66 papers in training set
Top 0.7%
1.8%
13
BMC Molecular and Cell Biology
14 papers in training set
Top 0.1%
1.7%
14
Cytotherapy
14 papers in training set
Top 0.2%
1.7%
15
Stem Cell Research
16 papers in training set
Top 0.1%
1.7%
16
Cancers
200 papers in training set
Top 3%
1.7%
17
Oncotarget
15 papers in training set
Top 0.1%
1.7%
18
Biology Open
130 papers in training set
Top 1%
1.4%
19
Medical Research Archives
11 papers in training set
Top 0.4%
1.1%
20
Molecular Biology Reports
19 papers in training set
Top 0.4%
1.0%
21
Life Sciences
25 papers in training set
Top 1%
0.9%
22
Cellular Signalling
14 papers in training set
Top 0.2%
0.8%
23
Frontiers in Genetics
197 papers in training set
Top 9%
0.8%
24
Biochemistry and Biophysics Reports
28 papers in training set
Top 1%
0.8%
25
Journal of Cellular Physiology
21 papers in training set
Top 0.7%
0.8%
26
American Journal of Physiology-Cell Physiology
34 papers in training set
Top 0.4%
0.7%
27
Biology
43 papers in training set
Top 3%
0.7%
28
FEBS Open Bio
29 papers in training set
Top 0.7%
0.7%
29
Genes
126 papers in training set
Top 4%
0.7%
30
Frontiers in Physiology
93 papers in training set
Top 7%
0.7%